/TOL.ST
TOL.ST Stock - Toleranzia AB
Healthcare|Drug Manufacturers - Specialty & GenericSTO
$0.48+1.92%
+$0.01 (+1.92%) • Aug 18
62
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.45
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.81
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.52
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for TOL.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.47 – $0.48
TARGET (TP)$0.55
STOP LOSS$0.44
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.98
52W High$0.72
52W Low$0.27
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $30.03M | $50.92M | $35.37M | $27.59M | $12.88M |
| Gross Profit | $-4,144,000 | $-919,000 | $70.62M | $54.71M | $25.02M |
| Gross Margin | -13.8% | -1.8% | 199.7% | 198.3% | 194.3% |
| Operating Income | $-10,248,000 | $-7,891,000 | $8.64M | $-6,281,747 | $-4,913,149 |
| Net Income | $-9,436,000 | $-7,459,000 | $-8,456,000 | $-6,283,865 | $-4,894,585 |
| Net Margin | -31.4% | -14.6% | -23.9% | -22.8% | -38.0% |
| EPS | $-0.04 | $-0.06 | $-0.08 | $-0.09 | $-0.09 |
Company Overview
Toleranzia AB, a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. The company is primarily developing TOL2 drug candidate for treating myasthenia gravis, an autoimmune nerve and muscle disease. It also intends to develop TOL3 drug candidate to treat ANCA vasculitis, an autoimmune blood vessel disease. In addition, the company develops tolerogens technology, a treatment method that creates disease-specific tolerance in the immune system for treating various autoimmune diseases. The company was founded in 2011 and is headquartered in Gothenburg, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
TOL.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.02
Q4 2024
EPS Surprise History
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q1 24
No data
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Dec 31, 2024 | — | $-0.02 | — | — |
Q3 2024 | Sep 29, 2024 | — | $-0.01 | — | — |
Q2 2024 | Jun 29, 2024 | — | $-0.01 | — | — |
Q2 2024 | Jun 6, 2024 | — | $-0.01 | — | — |
Q1 2024 | Mar 30, 2024 | — | $-0.00 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.01 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.02 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.02 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.02 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.02 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.02 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.02 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.02 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.02 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.03 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.03 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.03 | — | — |
Q4 2020 | Nov 2, 2020 | — | $-0.04 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.02 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.07 | — | — |
Latest News
Loading news...
Frequently Asked Questions about TOL.ST
What is TOL.ST's current stock price?
Toleranzia AB (TOL.ST) is currently trading at $0.48 per share. The stock has moved +1.92% today.
What is the analyst price target for TOL.ST?
No analyst price targets are currently available for this stock.
What sector is Toleranzia AB in?
Toleranzia AB operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the STO exchange.
What is TOL.ST's market cap?
Toleranzia AB has a market capitalization of $0.13 billion, making it a small-cap company.
Does TOL.ST pay dividends?
No, Toleranzia AB does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAROC.ST
AroCell AB (publ)
$0.57
Mkt Cap: $0.1B
COMBI.ST
CombiGene AB (publ)
$2.47
Mkt Cap: $0.0B
DIGN.ST
Dignitana AB (publ)
$2.14
Mkt Cap: $0.2B
EMPLI.ST
Emplicure AB (publ)
$0.47
Mkt Cap: $0.0B
FRISQ.ST
FRISQ Holding AB (publ)
$0.70
Mkt Cap: $0.0B
IRRAS.ST
IRRAS AB (publ)
$0.16
Mkt Cap: $0.2B
ISR.ST
ISR Immune System Regulation Holding AB (publ)
$1.40
Mkt Cap: $0.1B
KAN.ST
Kancera AB (publ)
$0.30
Mkt Cap: $0.0B
LIPI.ST
Lipidor AB (publ)
$0.21
Mkt Cap: $0.2B
RLS.ST
RLS Global AB (publ)
$0.45
Mkt Cap: $0.0B
Explore stocks similar to TOL.ST for comparison